Ilsung Pharmaceuticals Co., Ltd.

KSE 003120.KS

Ilsung Pharmaceuticals Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 6,993,489

Ilsung Pharmaceuticals Co., Ltd. Shares (Diluted, Weighted) is 6,993,489 for the year ending December 31, 2023, a -81.30% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Ilsung Pharmaceuticals Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 37,388,475, a 387.54% change year over year.
Ilsung Pharmaceuticals Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 7,668,840, a 0.00% change year over year.
Ilsung Pharmaceuticals Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 7,668,840, a 10.92% change year over year.
Ilsung Pharmaceuticals Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 6,914,045, a 2.91% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

KSE: 003120.KS

Ilsung Pharmaceuticals Co., Ltd.

CEO	Mr. Seok-geun Yoon
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	84-gil 9, Wonhyo-ro
Employees	224
Sector	Health Care
Industries Pharmaceuticals

Description

Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years